Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $19.29, but opened at $21.6950. Hikma Pharmaceuticals shares last traded at $21.6950, with a volume of 200 shares traded.
Hikma Pharmaceuticals Trading Up 7.9%
The firm’s 50-day moving average price is $19.40 and its two-hundred day moving average price is $19.38. The company has a current ratio of 1.82, a quick ratio of 1.06 and a debt-to-equity ratio of 0.57.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
- Lockheed Martin Secures the Ultimate Defense Moat
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
